Author： Geary Richard S
Publisher： Informa Healthcare
ISSN： 1742-5255
Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.5, Iss.4, 2009-04, pp. : 381-391
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Antisense oligonucleotide therapeutics
By Bennett C.F.
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 3, 1999-03 ,pp. :
Access to resources
Recommend
Antisense Anticancer Oligonucleotide Therapeutics
Current Cancer Drug Targets, Vol. 1, Iss. 3, 2001-01 ,pp. :
Antisense Oligonucleotide Drug Design
Current Pharmaceutical Design, Vol. 10, Iss. 7, 2004-03 ,pp. :
Antisense and / or Immunostimulatory Oligonucleotide Therapeutics
Current Cancer Drug Targets, Vol. 1, Iss. 3, 2001-11 ,pp. :